Navigation Links
Joseph Loscalzo, M.D., PhD. to Join N30 Pharma Board and Chair Scientific Advisory Board
Date:3/23/2009

BOULDER, Colo., March 23 /PRNewswire/ -- N30 Pharma (N30) today announced that Joseph Loscalzo, M.D., PhD., has joined the Board of Directors of the Company.

Dr. Loscalzo currently serves as Hersey Professor of the Theory and Practice of Medicine at Harvard, Physician-in-Chief at Brigham and Women's Hospital, Editor-in-Chief of Circulation, and has recently joined the senior editorial Board of Harrison's Principles of Internal Medicine. Dr. Loscalzo has longstanding research interests in cardiovascular medicine, nitric oxide and redox biology with over 500 scientific publications and authoring or editing of 24 books.

"I am pleased to join the Board of N30 at an exciting time for the company. N30 is developing compounds of substantial potential importance that offer a unique means for modulating endogenous NO in the cardiovascular and pulmonary systems, and I look forward to helping the Board in managing the future of the Company," Dr. Loscalzo commented.

Dr. Loscalzo will also Chair the company's Scientific Advisory Board. The N30 SAB will provide the company with world-class thinking on the key biological, biochemical, translational, and clinical issues associated with developing important new classes of therapeutics in cardiopulmonary medicine.

Dr. Charles Scoggin, CEO of N30, commented on the expansion of the Board. "We are thrilled that a world-class clinical and scientific mind like Dr. Loscalzo shares our excitement over the great clinical potential in N30 Pharma, and we will look forward to working closely with him as we move the company forward."

About N30 Pharma

N30 Pharma is a cardiopulmonary medicine company focused on the modulation of endogenous Nitric Oxide bioavailability using targeted novel small molecule drugs. The company is headquartered in Boulder, Colorado and New York City, NY.


'/>"/>
SOURCE N30 Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. PAREXEL Appoints Josephine Hoppe to Chief Information Officer
2. St. Josephs Hospital and Medical Center to Utilize Clinical InfoNET System for Physicians
3. Board of Directors of Milestone Scientific Names Joseph DAgostino Chief Financial Officer
4. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
5. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
6. Spherics, Inc. Assigns Assets to Joseph F. Finn, Jr., C.P.A.
7. Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBCs Drug Discovery & Development of Innovative Therapeutics Conference
8. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
9. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
10. SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors
11. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... , Jan. 24, 2017  Neogen Corporation (NASDAQ: ... terminated its agreement with SenesTech Incorporated (NASDAQ: ... a rodenticide being developed by SenesTech. The two firms ... time when the SenesTech product was approved by the ... approval provided that the product could only be used ...
(Date:1/24/2017)... and DURHAM, N.C. , ... IRB in customer service and technology, announces that ... the organization as Biosafety Officer. In ... leadership to develop and manage a forthcoming institutional biosafety ... for research organizations navigating the IBC landscape. The new ...
(Date:1/24/2017)... 2017  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... medicine, today announced positive efficacy results from the ... showed additional motor function improvement at 6-months and ... in AIS-A patients with complete cervical spinal cord ... motor function is critically important to patients with ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... waist circumference, and increased serum leptin levels had a positive association with increased ... The study published in the International Neurourology Journal involved 571 Korean men ...
Breaking Biology Technology:
(Date:12/22/2016)... -- As part of its longstanding mission to improve genetic literacy ... released its latest children,s book, titled The One ... topics of inheritance and variation of traits that are part ... school classrooms in the US. The book ... Killoran , whose previous book with 23andMe, You ...
(Date:12/20/2016)... , Dec. 20, 2016 The ... sharing, rental and leasing is stoking significant interest ... radio frequency technology, Bluetooth low energy (BLE), biometrics ... as the next wave of wireless technologies in ... access system to advanced access systems opens the ...
(Date:12/19/2016)... , España y TORONTO , 19 de ... con Northern Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, ... clínicos en varios tipos de tumor en 2017, con múltiples sitios ... ... su clase con objetivo en el factor inhibidor de leucemia (LIF), ...
Breaking Biology News(10 mins):